Short Term Evaluation of the Soothing and Re-epithelizing Activity of Three Topical Products and Relative Combinations
1 other identifier
interventional
20
1 country
1
Brief Summary
Aim of the study was to evaluate the soothing and re-epithelizing activity of a single application of topical products on experimentally induced erythema by skin stripping on the forearm (volar surface) of 20 healthy volunteers. In particular the activity of the following three cosmetic products and the relative combinations (cream and serum) were assessed: rejuvenating cream, rejuvenating serum, antioxidant serum
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3 healthy
Started Dec 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 18, 2014
CompletedFirst Posted
Study publicly available on registry
September 16, 2014
CompletedSeptember 16, 2014
March 1, 2014
Same day
July 18, 2014
September 12, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical evaluation of skin erythema: change from baseline, 1 hour after products application (T1h vs. T0)
Skin erythema was scored and recorded according to the following grades: 0=no erythema; 0.5=very slight erythema (barely perceptible);1=well-defined erythema;1.5=moderate to severe erythema; 2=severe erythema (beet redness) to slight eschar formation (injuries in depth)
After 1 (T1h) hour from products application
Secondary Outcomes (8)
Clinical evaluation of skin erythema: change from baseline, 6 hours from products application (T6h vs. T0)
After 6 (T6h) hours from products application
Clinical evaluation of skin erythema: change from baseline, after 24 hours from products application (T24h vs. T0)
After 24 (T24h) hours from products application
Optical densitometry: change from baseline, after 1hour from products application (T1h vs. T0)
After 1 (T1h) hour from products application
Optical densitometry: change from baseline, 6 hours from products application (T6h vs. T0)
After 6 (T6h) hours from products application
Optical densitometry: change from baseline, 24 hours from products application (T24h vs.T0)
After 24 (T24h) hours from products application
- +3 more secondary outcomes
Study Arms (5)
plantaricin a - rejuvenating cream
ACTIVE COMPARATORsingle application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes
plantaricin a - rejuvenating serum
ACTIVE COMPARATORsingle application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes
plantaricin a - antioxidant serum
ACTIVE COMPARATORsingle application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes
plantaricin a (rejuvenating cream +rejuvenating serum)
ACTIVE COMPARATORsingle application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes
plantaricin a (rejuvenating cream + antioxidant serum)
ACTIVE COMPARATORsingle application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes
Interventions
single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes
single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes
single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes
Eligibility Criteria
You may qualify if:
- Adult volunteers of both sexes, aged more than 18 years old
- Volunteers in a good general state of health in the Investigator opinion
- Volunteers not taking drugs or undergoing surgical procedure
- Volunteers who are giving a written informed consent.
You may not qualify if:
- Pregnancy (only for female subjects)
- lactation (only for female subjects)
- change in the normal habits in the last month
- participation in a similar study during the previous month
- known allergy to one or several ingredients of the products on trial
- insufficient adhesion to the study protocol
- dermatological disease
- clinical and significant skin condition on the test area (e.g. lesions, scars, malformations)
- diabetes
- endocrine disease
- hepatic, renal or cardiac disorder
- cancer
- topical drugs or surgical procedure on the test areas during the previous 3 months
- systemic corticosteroids
- aspirin or non-steroid anti-inflammatory drugs (FANS)
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Derming SRLlead
Study Sites (1)
DermIng SRL
Monza, Monza, 20900, Italy
Related Publications (21)
Buonocore D, Lazzeretti A, Tocabens P, Nobile V, Cestone E, Santin G, Bottone MG, Marzatico F. Resveratrol-procyanidin blend: nutraceutical and antiaging efficacy evaluated in a placebocontrolled, double-blind study. Clin Cosmet Investig Dermatol. 2012;5:159-65. doi: 10.2147/CCID.S36102. Epub 2012 Oct 5.
PMID: 23071399BACKGROUNDBenzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996 Jul 15;239(1):70-6. doi: 10.1006/abio.1996.0292.
PMID: 8660627BACKGROUNDBradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248-54. doi: 10.1016/0003-2697(76)90527-3. No abstract available.
PMID: 942051BACKGROUNDCalcabrini C, De Bellis R, Mancini U, Cucchiarini L, Potenza L, De Sanctis R, Patrone V, Scesa C, Dacha M. Rhodiola rosea ability to enrich cellular antioxidant defences of cultured human keratinocytes. Arch Dermatol Res. 2010 Apr;302(3):191-200. doi: 10.1007/s00403-009-0985-z. Epub 2009 Aug 25.
PMID: 19705137BACKGROUNDCorcuff P, Chatenay F, Leveque JL. A fully automated system to study skin surface patterns. Int J Cosmet Sci. 1984 Aug;6(4):167-76. doi: 10.1111/j.1467-2494.1984.tb00373.x.
PMID: 19467109BACKGROUNDDe Jongh CM, Verberk MM, Withagen CE, Jacobs JJ, Rustemeyer T, Kezic S. Stratum corneum cytokines and skin irritation response to sodium lauryl sulfate. Contact Dermatitis. 2006 Jun;54(6):325-33. doi: 10.1111/j.0105-1873.2006.00848.x.
PMID: 16787454BACKGROUNDInt J Cosm Sci 6: 167-186, 1984 Fernay, Voltaire The World Medical Association (1989)
BACKGROUNDElsner P, Barel AO, Berardesca E, Gapard B, Serup J Skin Bioengineering Techniques and Applications in Dermatology and Cosmetology Karger, 1998
BACKGROUNDFuga GC, Spina C, Cavallotti C, Di Palma A, Lombardi G, Marmo W Computerized reflected optical densitometry. A research on the colour of the skin. Journal of Applied Cosmetology, 8:91-110,1990
BACKGROUNDFullerton A, Fischer T, Lahti A, Wilhelm KP, Takiwaki H, Serup J. Guidelines for measurement of skin colour and erythema. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis. 1996 Jul;35(1):1-10. doi: 10.1111/j.1600-0536.1996.tb02258.x.
PMID: 8896947BACKGROUNDGarcia Ortiz P, Hansen SH, Shah VP, Menne T, Benfeldt E. Impact of adult atopic dermatitis on topical drug penetration: assessment by cutaneous microdialysis and tape stripping. Acta Derm Venereol. 2009;89(1):33-8. doi: 10.2340/00015555-0562.
PMID: 19197539BACKGROUNDGrove GL, Zerweck CR, Houser TP, Smith GE, Koski NI. A randomized and controlled comparison of gentleness of 2 medical adhesive tapes in healthy human subjects. J Wound Ostomy Continence Nurs. 2013 Jan-Feb;40(1):51-9. doi: 10.1097/WON.0b013e318276f2a4.
PMID: 23202590BACKGROUNDICH Harmonised Tripartite Guideline - Guideline for Good Clinical Practice International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: May 1996
BACKGROUNDLademann J, Meinke MC, Schanzer S, Richter H, Darvin ME, Haag SF, Fluhr JW, Weigmann HJ, Sterry W, Patzelt A. In vivo methods for the analysis of the penetration of topically applied substances in and through the skin barrier. Int J Cosmet Sci. 2012 Dec;34(6):551-9. doi: 10.1111/j.1468-2494.2012.00750.x. Epub 2012 Sep 25.
PMID: 22957937BACKGROUNDLademann J, Jacobi U, Surber C, Weigmann HJ, Fluhr JW. The tape stripping procedure--evaluation of some critical parameters. Eur J Pharm Biopharm. 2009 Jun;72(2):317-23. doi: 10.1016/j.ejpb.2008.08.008. Epub 2008 Aug 19.
PMID: 18775778BACKGROUNDLindemann U, Wilken K, Weigmann HJ, Schaefer H, Sterry W, Lademann J. Quantification of the horny layer using tape stripping and microscopic techniques. J Biomed Opt. 2003 Oct;8(4):601-7. doi: 10.1117/1.1609200.
PMID: 14563197BACKGROUNDMarttin E, Neelissen-Subnel MT, De Haan FH, Bodde HE. A critical comparison of methods to quantify stratum corneum removed by tape stripping. Skin Pharmacol. 1996;9(1):69-77. doi: 10.1159/000211392.
PMID: 8868035BACKGROUNDSachs L Applied statistics: a handbook of techniques. Heidelberg: Springer, 1981:536-539
BACKGROUNDSerup J, Agner T. Colorimetric quantification of erythema--a comparison of two colorimeters (Lange Micro Color and Minolta Chroma Meter CR-200) with a clinical scoring scheme and laser-Doppler flowmetry. Clin Exp Dermatol. 1990 Jul;15(4):267-72. doi: 10.1111/j.1365-2230.1990.tb02087.x.
PMID: 2208776BACKGROUNDTakiwaki H. Measurement of skin color: practical application and theoretical considerations. J Med Invest. 1998 Feb;44(3-4):121-6.
PMID: 9597799BACKGROUNDWeigmann H, Lademann J, Meffert H, Schaefer H, Sterry W. Determination of the horny layer profile by tape stripping in combination with optical spectroscopy in the visible range as a prerequisite to quantify percutaneous absorption. Skin Pharmacol Appl Skin Physiol. 1999 Jan-Apr;12(1-2):34-45. doi: 10.1159/000029844.
PMID: 10325582BACKGROUND
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Adele Sparavigna, Doctor
Derming SRL
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 18, 2014
First Posted
September 16, 2014
Study Start
December 1, 2013
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
September 16, 2014
Record last verified: 2014-03